 |
AbbVie
ABBV
|
24.1 |
$ 263.04 |
0.49 % |
$ 465 B |
USA |
 |
AbCellera Biologics
ABCL
|
12.8 |
$ 11.41 |
2.15 % |
$ 3.41 B |
Canada |
 |
Фармсинтез
LIFE
|
5.39 |
- |
- |
- |
Russia |
 |
Aclaris Therapeutics
ACRS
|
49.2 |
$ 5.53 |
6.02 % |
$ 678 M |
USA |
 |
ADC Therapeutics SA
ADCT
|
1.7 |
$ 1.09 |
3.74 % |
$ 139 M |
Schweiz |
 |
Amryt Pharma plc
AMYT
|
11.4 |
- |
- |
$ 621 M |
Britain |
 |
Clovis Oncology
CLVS
|
7.29 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Chimerix
CMRX
|
320 |
- |
- |
$ 756 M |
USA |
 |
Concert Pharmaceuticals
CNCE
|
3.2 |
- |
- |
$ 401 M |
USA |
 |
ADMA Biologics
ADMA
|
7.41 |
$ 8.61 |
0.16 % |
$ 2.05 B |
USA |
 |
Eiger BioPharmaceuticals
EIGR
|
0.197 |
- |
-9.21 % |
$ 2.55 M |
USA |
 |
Guardion Health Sciences
GHSI
|
0.642 |
- |
-0.31 % |
$ 3.64 M |
USA |
 |
Genocea Biosciences
GNCA
|
44.3 |
- |
-15.0 % |
$ 3.04 M |
USA |
 |
Gritstone Oncology
GRTS
|
16.9 |
- |
0.42 % |
$ 213 M |
USA |
 |
G1 Therapeutics
GTHX
|
2.1 |
- |
- |
$ 370 M |
USA |
 |
Harpoon Therapeutics
HARP
|
0.676 |
- |
- |
$ 763 M |
USA |
 |
Humanigen
HGEN
|
4.97 |
- |
-81.12 % |
$ 4.28 M |
USA |
 |
HOOKIPA Pharma
HOOK
|
0.333 |
- |
-6.92 % |
$ 79.4 M |
USA |
 |
Intercept Pharmaceuticals
ICPT
|
9.15 |
- |
- |
$ 643 M |
USA |
 |
IMV
IMV
|
48.2 |
- |
- |
$ 13.1 M |
Canada |
 |
Intra-Cellular Therapies
ITCI
|
66.5 |
- |
- |
$ 13.6 B |
USA |
 |
Chinook Therapeutics
KDNY
|
227 |
- |
- |
$ 2.6 B |
USA |
 |
Kaleido Biosciences
KLDO
|
66.7 |
- |
-3.69 % |
$ 12.4 M |
USA |
 |
Kronos Bio
KRON
|
11 |
- |
1.49 % |
$ 50.8 M |
USA |
 |
Karuna Therapeutics
KRTX
|
18 K |
- |
- |
$ 12.2 B |
USA |
 |
Landos Biopharma
LABP
|
7.16 |
- |
0.58 % |
$ 144 M |
USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
1.68 |
- |
- |
$ 154 M |
USA |
 |
LogicBio Therapeutics
LOGC
|
13.8 |
- |
- |
$ 229 M |
USA |
 |
Lumos Pharma
LUMO
|
12 |
- |
- |
$ 35.3 M |
USA |
 |
Merrimack Pharmaceuticals
MACK
|
0.804 |
- |
- |
$ 216 M |
USA |
 |
Stealth BioTherapeutics Corp
MITO
|
44.9 |
- |
- |
$ 23.9 M |
USA |
 |
Mirati Therapeutics
MRTX
|
206 |
- |
- |
$ 3.3 B |
USA |
 |
9 Meters Biopharma
NMTR
|
38.5 |
- |
-42.97 % |
$ 1.05 M |
USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
38.5 K |
- |
-19.68 % |
$ 18.4 M |
Canada |
 |
Oncternal Therapeutics
ONCT
|
34.8 |
- |
-24.12 % |
$ 1.56 M |
USA |
 |
Opiant Pharmaceuticals
OPNT
|
2.44 |
- |
- |
$ 109 M |
USA |
 |
Orchard Therapeutics plc
ORTX
|
29.7 |
- |
1.02 % |
$ 90.8 M |
Britain |